Want to see JP:4350 full AI Analyst Report?
4350 Stock Chart & Stats
¥521.00
-¥6.00(-1.44%)
At close: 4:00 PM EST
¥521.00
-¥6.00(-1.44%)
Day’s Range― - ―
52-Week Range¥433.00 - ¥558.00
Previous CloseN/A
Volume13.10K
Average Volume (3M)49.94K
Market Cap
¥14.27B
Enterprise Value¥43.60B
Total Cash (Recent Filing)¥8.74B
Total Debt (Recent Filing)¥25.01B
Price to Earnings (P/E)12.9
Beta0.71
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.32%
Share Statistics
EPS (TTM)40.04
Shares Outstanding30,642,600
10 Day Avg. Volume63,720
30 Day Avg. Volume49,936
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)0.91
Price to Sales (P/S)0.12
P/FCF Ratio-2.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)99.2
Revenue Forecast (FY)¥134.00B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthMid-single-digit revenue growth over recent years indicates durable end-market demand and successful commercial execution. Sustained top-line expansion supports scale economics, helps absorb fixed costs, and provides a platform for margin recovery if cost pressures are managed.
Improving Balance Sheet TrajectoryA falling absolute debt level and rising equity point to gradual de-leveraging, which enhances financial flexibility over the medium term. Continued improvement reduces refinancing risk and gives management more optionality for capex, R&D, or conservative dividend policy.
Healthy Gross ProfitSustained gross profitability implies the core business retains pricing power or favorable cost of goods structure. That base makes operational fixes or SG&A optimization more likely to translate into improved operating margins once non-operating or one-off pressures are addressed.
Bears Say
Negative Operating & Free Cash FlowA sharp cash-flow reversal in 2026 signals working-capital strain or higher cash outlays, undermining the company's ability to self-fund growth, capex, or distributions. Persistent cash burn increases dependence on external financing and heightens liquidity and refinancing risk.
Declining ProfitabilityConsecutive net income declines and low operating profitability indicate margin erosion from cost inflation, pricing pressure, or non-operating losses. Thin operating margins reduce resilience to revenue cycles and limit retained earnings available for reinvestment or debt reduction.
Elevated LeverageA debt-heavy capital structure relative to equity increases financial fragility, raising interest burden and constraining strategic choices. Even with recent debt reduction, leverage near this level magnifies the impact of earnings volatility and raises default or covenant risk in stress scenarios.
Medical System Network Co., Ltd. News
4350 FAQ
What was Medical System Network Co., Ltd.’s price range in the past 12 months?
Medical System Network Co., Ltd. lowest stock price was ¥433.00 and its highest was ¥558.00 in the past 12 months.
What is Medical System Network Co., Ltd.’s market cap?
Medical System Network Co., Ltd.’s market cap is ¥14.27B.
When is Medical System Network Co., Ltd.’s upcoming earnings report date?
Medical System Network Co., Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 36 days.
How were Medical System Network Co., Ltd.’s earnings last quarter?
Medical System Network Co., Ltd. released its earnings results on May 08, 2026. The company reported ¥2.08 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.08.
Is Medical System Network Co., Ltd. overvalued?
According to Wall Street analysts Medical System Network Co., Ltd.’s price is currently Overvalued.
Does Medical System Network Co., Ltd. pay dividends?
Medical System Network Co., Ltd. pays a Semiannually dividend of ¥5.953 which represents an annual dividend yield of 2.32%. See more information on Medical System Network Co., Ltd. dividends here
What is Medical System Network Co., Ltd.’s EPS estimate?
Medical System Network Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical System Network Co., Ltd. have?
Medical System Network Co., Ltd. has 30,642,600 shares outstanding.
What happened to Medical System Network Co., Ltd.’s price movement after its last earnings report?
Medical System Network Co., Ltd. reported an EPS of ¥2.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.942%.
Which hedge fund is a major shareholder of Medical System Network Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4350
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical System Network Co., Ltd.
Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse range of clients, including pharmacies, hospitals, clinics, and drug wholesalers. The company's operations are divided into several key segments. The Community Pharmacy Network division primarily facilitates the procurement and sale of pharmaceuticals among pharmacies, hospitals, clinics, and wholesale distributors. This segment also delivers crucial inventory management and liquidation services, manufactures and markets its own pharmaceutical offerings, and handles price negotiations with suppliers. Furthermore, it maintains a specialized platform designed to assist with pharmacy transitions. Within the Leasing and Facility-related segment, Medical System Network provides building rental services, develops optimal locations for new pharmacies, and offers consulting expertise to medical practitioners. The Meal Catering segment is responsible for delivering food services to hospitals and various welfare facilities. Beyond these primary areas, the company also offers nursing care and specialized advisory counseling services tailored for the medical treatment sector.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---